Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion.

Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion.

Incretins, hormones released by the gut after meal ingestion, are essential for maintaining systemic glucose homeostasis by stimulating insulin secretion. The effect of incretins on insulin secretion occurs only at elevated glucose concentrations and is mediated by cAMP signaling, but the mechanism ...

Descripció completa

Dades bibliogràfiques
Autors principals:	Gheni, G, Ogura, M, Iwasaki, M, Yokoi, N, Minami, K, Nakayama, Y, Harada, K, Hastoy, B, Wu, X, Takahashi, H, Kimura, K, Matsubara, T, Hoshikawa, R, Hatano, N, Sugawara, K, Shibasaki, T, Inagaki, N, Bamba, T, Mizoguchi, A, Fukusaki, E, Rorsman, P, Seino, S
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2014

Ítems similars

Glutamate Acts as a Key Signal Linking Glucose Metabolism to Incretin/cAMP Action to Amplify Insulin Secretion
per: Ghupurjan Gheni, et al.
Publicat: (2014-10-01)

Stimulatory effect of imeglimin on incretin secretion
per: Quan Yingyue, et al.
Publicat: (2023-06-01)

Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in β-cell glutamate signaling for incretin-induced insulin secretion.
per: Naoya Murao, et al.
Publicat: (2017-01-01)

Action of incretins on the pancreatic alpha cell
per: McCulloch, L, et al.
Publicat: (2015)

The journey to understanding incretin systems: Theory, practice and more theory
per: Daisuke Yabe, et al.
Publicat: (2019-09-01)

Why Are Incretin-Based Therapies More Efficient in East Asians? Perspectives from the Pathophysiology of Type 2 Diabetes and East Asian Dietary Habits
per: Daisuke Yabe, et al.
Publicat: (2015-11-01)

The integrated incretin effect is reduced by both glucose intolerance and obesity in Japanese subjects
per: Akihiro Hamasaki, et al.
Publicat: (2024-06-01)

An analysis of intestinal morphology and incretin-producing cells using tissue optical clearing and 3-D imaging
per: Tomonobu Hatoko, et al.
Publicat: (2022-10-01)

Tumor‐like features of gene expression and metabolic profiles in enlarged pancreatic islets are associated with impaired incretin‐induced insulin secretion in obese diabetes: A study of Zucker fatty diabetes mellitus rat
per: Tomohide Hayami, et al.
Publicat: (2020-11-01)

Inflammation and Incretins
per: Amitabh Hatwal
Publicat: (2012-01-01)

Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1.
per: Gromada, J, et al.
Publicat: (1998)

The associations of incretin hormone concentration with gestational diabetes mellitus
per: Tatiana V. Saprina, et al.
Publicat: (2016-05-01)

Incretin Mimetics in the Indian Context: Revisiting Exenatide
per: Shambo S Samajdar, et al.
Publicat: (2022-08-01)

Pleiotropic effects of incretins
per: Vishal Gupta
Publicat: (2012-01-01)

Recent clinical and pharmacological advancements of incretin-based therapy and the effects of incretin on physiology
per: Bhaskar Pal, et al.
Publicat: (2024-01-01)

Does Incretin Agonism Have Sustainable Efficacy?
per: Sok-Ja Janket, et al.
Publicat: (2024-11-01)

The Gut Microbiome’s Influence on Incretins and Impact on Blood Glucose Control
per: Ajay S. Dulai, et al.
Publicat: (2024-11-01)

Incretin hormones as immunomodulators of atherosclerosis
per: Nuria eAlonso, et al.
Publicat: (2012-09-01)

Understanding the Cardiovascular Effects of Incretin
per: Ji Sung Yoon, et al.
Publicat: (2011-10-01)

Incretins in patients with rheumatoid arthritis
per: Beatriz Tejera-Segura, et al.
Publicat: (2017-10-01)

Stimulation of incretin secreting cells
per: Ramona Pais, et al.
Publicat: (2016-02-01)

Abnormal gut microbiota and impaired incretin effect as a cause of type 2 diabetes mellitus
per: T. Y. Demidova, et al.
Publicat: (2022-03-01)

Achieving equitable access to incretin-based therapies in cardiovascular care
per: Tina K. Reddy, et al.
Publicat: (2024-10-01)

Role of fasting duration and weekday in incretin and glucose regulation
per: Kim K B Clemmensen, et al.
Publicat: (2020-04-01)

Recent advances in incretin-based therapies.
per: Russell-Jones, D, et al.
Publicat: (2012)

Incretin Effects and Enteral Feed Transitions
per: Ummu Kulthum, Jamaludin, et al.
Publicat: (2014)

Mechanisms of neuroprotective action of incretin mimetics
per: Timur Dmitrievich Vlasov, et al.
Publicat: (2016-01-01)

Incretin-based therapy: renal effects
per: Anton Ivanovich Korbut, et al.
Publicat: (2016-01-01)

Harnessing the Incretin System with Multi-Agonists
per: Martin B Whyte, et al.
Publicat: (2022-10-01)

Editorial: Incretin agonists in the treatment of obesity
per: Xiaodong Sun, et al.
Publicat: (2023-08-01)

Symposium 19: Secretagogues: sulfonylureas and incretins
per: Víctor Commendatore
Publicat: (2020-11-01)

Insulin and incretin responses to grazing in insulin‐dysregulated and healthy ponies
per: Danielle M. Fitzgerald, et al.
Publicat: (2019-01-01)

PANCREATIC AND EXTRA-PANCREATIC EFFECTS OF INCRETINS AND PERSPECTIVES FOR STUDYING ENTEROINSULIN HORMONAL SYSTEM DURING GESTATIONAL DISORDER OF CARBOHYDRATE METABOLISM
per: T. V. Saprina, et al.
Publicat: (2013-06-01)

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
per: Joan Khoo, et al.
Publicat: (2009-08-01)

SAVOR-TIMI to DECLARE-TIMI: A review on cardiovascular outcome trials of incretin-modulators and gliflozins
per: Awadhesh K Singh, et al.
Publicat: (2019-01-01)

Impact of Incretin-Based Therapies on Adipokines and Adiponectin
per: Habib Yaribeygi, et al.
Publicat: (2021-01-01)

The Impact of Incretin-Based Medications on Lipid Metabolism
per: Habib Yaribeygi, et al.
Publicat: (2021-01-01)

Incretins today: multiple effects and therapeutic potential
per: Oksana V. Tsygankova, et al.
Publicat: (2019-03-01)

Anti-atherosclerotic effect of incretin receptor agonists
per: Xin Wang, et al.
Publicat: (2024-10-01)

Tirzepatide – a new analogue of incretin hormones
per: Gabriela Anglart, et al.
Publicat: (2023-10-01)